Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,597 | -963 | -4,528 | -3,530 | -2,920 |
| Depreciation Amortization | 135 | 92 | 77 | 47 | 17 |
| Other Working Capital | 464 | 157 | 2,171 | 1,327 | 668 |
| Other Operating Activity | 69 | 23 | 583 | 602 | 826 |
| Operating Cash Flow | $-930 | $-691 | $-1,697 | $-1,554 | $-1,410 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -22 | -22 | -37 | -9 | -9 |
| Other Investing Activity | -22 | -22 | -37 | -9 | -9 |
| Investing Cash Flow | $-22 | $-22 | $-37 | $-9 | $-9 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,381 | 1,381 | 1,165 | 1,165 | 1,165 |
| Common Stock Issued | 0 | N/A | 600 | 600 | 600 |
| Financing Cash Flow | $1,381 | $1,381 | $1,765 | $1,765 | $1,765 |
| Beginning Cash Position | 72 | 72 | 42 | 42 | 42 |
| End Cash Position | 501 | 740 | 72 | 244 | 388 |
| Net Cash Flow | $428 | $667 | $31 | $202 | $346 |
| Free Cash Flow | |||||
| Operating Cash Flow | -930 | -691 | -1,697 | -1,554 | -1,410 |
| Free Cash Flow | -930 | -691 | -1,697 | -1,554 | -1,410 |